{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:47:48Z","timestamp":1767041268140,"version":"3.48.0"},"reference-count":32,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20210003"],"award-info":[{"award-number":["BK20210003"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Valproic acid (VPA), a classic antiepileptic drug with a narrow therapeutic window, is widely used in paediatric epilepsy treatment. As only the unbound fraction of the drug is a pharmacologically active component, we established a population pharmacokinetic (PopPK) model for both unbound and total VPA in epileptic children to provide a clinical optimisation strategy. A total of 450 epileptic children providing 620 samples were included for modelling development. In addition, trough unbound and total VPA concentrations were simulated for typical patients to propose the dose regimen. A one\u2010compartment model with first\u2010order absorption and elimination was well developed to describe the pharmacokinetic characteristics of unbound VPA, and the Langmuir equation was used to explore the protein binding parameters. The final model indicated that the CL\n                    <jats:sub>u<\/jats:sub>\n                    \/F of unbound VPA was significantly influenced by body weight, age\u2010based maturation and daily dose. Proposed dosing regimens for children aged 0 to 12\u2009years, simulated using the Monte Carlo method, recommended 10\u201330\u2009mg\/kg\/day, decreasing with age. This PopPK model of VPA could be helpful to propose recommended dosage regimens to achieve the target therapeutic concentration window in clinical practice.\n                  <\/jats:p>","DOI":"10.1111\/bcpt.70142","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T04:06:08Z","timestamp":1763352368000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population Pharmacokinetics Model and Simulation of Unbound and Total Valproic Acid in Epileptic Children Using a Protein Binding Model"],"prefix":"10.1111","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9672-0798","authenticated-orcid":false,"given":"Tingting","family":"Yue","sequence":"first","affiliation":[{"name":"Department of Neurosurgery Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University  Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Shengjing Hospital of China Medical University  Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2978-8308","authenticated-orcid":false,"given":"Ya'nan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Jiangsu Cancer Hospital &amp; Jiangsu Institute of Cancer Research &amp; the Affiliated Cancer Hospital of Nanjing Medical University  Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shansen","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Neurology and Oncology Drug Development Jiangsu Simcere Pharmaceutical Co., Ltd.  Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000503831"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.58"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X17666181227165722"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000546"},{"key":"e_1_2_10_6_1","unstructured":"Epilim Chronosphere\u2014Summary of Product Characteristics (SPC)[https:\/\/www.medicines.org.uk\/emc\/files\/pil.3988.pdf accessed 3 Sep. (2025)]."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32835ea0b2"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.43.s.3.5.x"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000431"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.04.012"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1965"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01171-w"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081208"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000405"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.636"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111066"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0212-8"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2440-6"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.06.033"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1228641"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13191"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13944"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000256"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03080-y"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2444-2"},{"issue":"9","key":"e_1_2_10_26_1","first-page":"629","article-title":"Pharmacokinetics of Valproic Acid After Administration of Three Oral Formulations in Healthy Adults[J]","volume":"38","author":"Bano G.","year":"1990","journal-title":"Journal of the Association of Physicians of India"},{"key":"e_1_2_10_27_1","article-title":"Comparison of Pharmacokinetics, Plasma Concentration and Efficacy Between Valproic Acid Sustained Released and Enteric\u2010Coated Tablets","volume":"26","author":"Hou Q.","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"issue":"7","key":"e_1_2_10_28_1","first-page":"487","article-title":"Height and Weight Standardized Growth Charts for Chinese Children and Adolescents Aged 0 to 18 Years","volume":"47","author":"Li H.","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198815060-00002"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)07335-0"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-005-0083-6"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2020.1707668"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00885.x"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.70142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:44:16Z","timestamp":1767041056000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcpt.70142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1111\/bcpt.70142"],"URL":"https:\/\/doi.org\/10.1111\/bcpt.70142","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"type":"print","value":"1742-7835"},{"type":"electronic","value":"1742-7843"}],"subject":[],"published":{"date-parts":[[2025,11,16]]},"assertion":[{"value":"2025-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70142"}}